Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of MenACYW Conjugate Vaccine in Older Pilgrims
NCT03869866Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2019
- Primary completion
- Mar 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal infection, sponsored by Sanofi. Started Apr 2019; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT03869866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03869866.